|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 405/06 | |
| C07D 405/06 | |||
| C07D 307/00 | |||
| C07D 213/00 |
| (11) | Patento numeris | 1701953 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05705212.8 |
| Europos patento paraiškos padavimo data | 2005-01-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-09-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-11-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/000447 |
| Data | 2005-01-07 |
| (87) | Numeris | WO 2005/070923 |
| Data | 2005-08-04 |
| (30) | Numeris | Data | Šalis |
| 755066 | 2004-01-09 | US |
| (72) |
THIRUVENGADAM, Tiruvettipuram, K., US
WU, Wenxue, US
WANG, Tao, US
CHIU, John, S., US
BOGDANOWICH-KNIPP, Susan, US
PAVLOVSKY, Anastasia, US
GREENLEE, William, J., US
GRAZIANO, Michael, P., US
KOSOGLOU, Teddy, US
CHINTALA, Madhu, US
CHACKALAMANNIL, Samuel, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | Process for the production of a crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| Process for the production of a crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |